Your browser doesn't support javascript.
loading
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies.
Antoniotti, Carlotta; Germani, Marco M; Rossini, Daniele; Lonardi, Sara; Pietrantonio, Filippo; Santini, Daniele; Marmorino, Federica; Allegrini, Giacomo; Daniel, Francesca; Raimondi, Alessandra; Borelli, Beatrice; Zaniboni, Alberto; Conca, Veronica; Abraham, Jim; Spetzler, David; Maiello, Evaristo; Boccaccino, Alessandra; Passardi, Alessandro; Giordano, Mirella; Tamburini, Emiliano; Korn, Michael W; Masi, Gianluca; Cremolini, Chiara.
Afiliação
  • Antoniotti C; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Germani MM; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Rossini D; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Lonardi S; Medical Oncology Unit 3, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.
  • Santini D; Department of Medical Oncology, University Campus Biomedico, Roma, Italy.
  • Marmorino F; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Allegrini G; Department of Oncology, Division of Medical Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.
  • Daniel F; Medical Oncology Unit 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.
  • Borelli B; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Zaniboni A; Medical Oncology Unit, Poliambulanza Foundation, Brescia, Italy.
  • Conca V; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Abraham J; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Spetzler D; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Maiello E; Oncology Unit, Foundation IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
  • Boccaccino A; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Passardi A; Department of Medical Oncology, Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Giordano M; Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
  • Tamburini E; Oncology Unit, Ospedale Degli Infermi, Rimini, Italy; Oncology Department and Palliative Care, Cardinale Panico Tricase City Hospital, Italy.
  • Korn MW; Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA.
  • Masi G; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Electronic address: chiaracremolini@gmail.com.
Eur J Cancer ; 167: 23-31, 2022 05.
Article em En | MEDLINE | ID: mdl-35366570
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neutropenia Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neutropenia Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido